| __timestamp | Bio-Techne Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 504755000 |
| Thursday, January 1, 2015 | 119401000 | 838526000 |
| Friday, January 1, 2016 | 140879000 | 1177697000 |
| Sunday, January 1, 2017 | 199243000 | 1320433000 |
| Monday, January 1, 2018 | 240636000 | 1556200000 |
| Tuesday, January 1, 2019 | 264359000 | 1834800000 |
| Wednesday, January 1, 2020 | 260583000 | 1346000000 |
| Friday, January 1, 2021 | 324951000 | 1824900000 |
| Saturday, January 1, 2022 | 372766000 | 2115900000 |
| Sunday, January 1, 2023 | 378378000 | 2631300000 |
| Monday, January 1, 2024 | 396826000 | 2954400000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing costs is crucial for sustaining growth and innovation. This chart provides a fascinating glimpse into the Selling, General, and Administrative (SG&A) expenses of two industry giants: Regeneron Pharmaceuticals, Inc. and Bio-Techne Corporation, from 2014 to 2023.
Regeneron Pharmaceuticals has consistently outpaced Bio-Techne in SG&A spending, reflecting its expansive operations and aggressive market strategies. In 2023, Regeneron's SG&A expenses were approximately 2.6 billion, marking a staggering 420% increase from 2014. In contrast, Bio-Techne's expenses grew by about 550% over the same period, reaching nearly 400 million in 2023.
This data highlights the differing scales and strategies of these companies. While Regeneron's larger budget underscores its extensive reach, Bio-Techne's rapid growth in expenses suggests a strategic push to expand its market presence.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Evotec SE
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Comparing SG&A Expenses: Bio-Techne Corporation vs Corcept Therapeutics Incorporated Trends and Insights